Том 2, номер 1, Январь-Февраль 2011 г. /@@The Lancet Infectious Diseases 2011; 11(1): 39-44.
Fairley C.K. What can surveillance of genital warts tell us? / C.K. Fairley, B. Donovan // Sexual health 2010 Sep; 7(3): 325-7.
Feltkamp M.C. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types in associated with nonmelanoma skin cancer / M.C. Feltkamp, R. Broer, F.M. Summa et al. // Cancer Rec. 2003. - V.63, №10. - P.2695-2700.
Franco E. Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer / E. Franco et al. // New England Journal of Medicine 2007; 357: 1579-1588.
Frazer I.H. HPV vaccines / I. H. Frazer // International of Gynecology and Obstetrics 2006; 94 (1): 81-8.
Fischer G. Topical immunosupressants genital lichen sclerosus and the risk of sqamous cell carcinoma a case report / G. Fischer, J. Bradford // J. Reprod. Med. – 2007. -Vol. 57.- №4. – P. 329 – 331.
Garbe E. Incidence rates of anogenital warts in Germany / E. Garbe, T. Schink, R. Schulze-Rath et al. // Аbstracts of 26 HPV conference. – Montreal.- 2010.
Gravitt P.E. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV 16 load predicts the development of incident disease / P. E. Gravitt, M. Butsch Kovacic, R. Herrero et al. // International Journal of Cancer. – 2008. – Vol. 121, №12. – P. 2787 – 2793.
Hampl M. New aspects in vulvar cancer: changes in localization and age of onset. / M. Hampl, S. Deckers-Figiel, J.A. Hampl, D. Rain, H.G. Bender // Gynecol. Oncol.- 2008; 109: 340-5.
Herrero R. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study / R. Herrero, X. Castellsague, M. Pawlita // Journal of the National Cancer Institute.-2003.-Vol. 95.-N 23.-P. 1772–1783.
Katki H.A. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population – based study in routine clinical practice / H.A. Katki, W.K. Kinney, B.Fetterman, T. Lorey, N.E. Poitras, L. Cheung, F. Demuth, M. Schiffman, S. Wacholder, P.E. Castle// Lancet Oncol. 2011. - Jul; 12 (7):663-72.
Kenter G.G. Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia / G.G Kenter et al. // New England Journal of Medicine. 2010; 362: 655-656.
Kim J.J. Cost – effectiveness of alternative triage studies for atypical squamous cells of undetermined significance / J.J. Kim, T.C. Wright., S.J. Goldie // JAMA.-2002.-Vol.287.-P.2382-2390.
Kim J.J. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, the Netherlands, France and Italy / J.J. Kim, T.C. Wright, S.J. Goldie // Journal of the National Cancer Institute 2005; 97 (12): 888-895.
Kitchener H.C., Peto J., Wheeler P. et al. ARTISTIC: a randomized train of human papillomavirus (HPV) testing in primary cervical screening. Health Technol Assess.2009 Nov.-13(51):1-150.
Kjaer S.K. Type specific persistence of high risk human papilloma virus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study / S.K. Kjaer, A.J. van der Brule, G. Paull et al. // British Medical Journal. - 2002. - 325: 572.
Klein S.L. Sex differences in susceptibility to viral infection / Sabra L Klein, Anne Jedlicka, Andrew Pekosz // Том 2, номер 1, Январь-Февраль 2011 г. /@@The Lancet Infectious Diseases. - 2010 (1). - №4. - P. 93-122.
Kwasnievska A. Chlamydia trachomatis and Herpes simplex virus 2 infection in vulvar intraepithelial neoplasia associated with human papillomavirus / A. Kwasnievska, E. Korobowisz, J. Visconti et al. // Gynaecolog. Oncol.-2006; Vol.66; 4: 405-408.
Lacey J.V. Asensitive, type-specific, fluorogenic probe assay for detection of human papillomavirus DNA / J.V. Lacey, C.A. Swanson, L.A. Brinton et al. // Cancer 2003 // V.98.-№4.-P.814-821.
Maaike A. Vaginal and (Uncommon) cervical cancer in the Netherlands, 1989 – 2003 / A. Maaike et al. // Int. J. Gynecol. Cancer. - 2010. - Vol.20. - P.138 – 143.
Medeiros L.R. Vertical trsnsmission of the human papillomavirus: a systematic quantitative review / L.R. Medeiros, A.B. Ethur, R.R. Zanini // Cad. Saude Publica, Rio de Janeiro 2005.-Vol. 21 (4). - P.1006-1015.
Mellin H. Prevaiance of High-Risk Human Papillomavirus DNA in Nonkeratinizing (Cylindrical Cell) Carcinoma of the Sinonasal Tract / H. Mellin, S. Friesland, G. Auer et al. // Anticancer. Res. 2003.-V.23. - №3. - P.2821-2828.
Moscicki A.B. HPV infections in adolescents / A.B. Moscicki // Disease Markers. - 2007. - 73: 229 – 34.
Moyer V.A. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement / V.A. Moyer // June 2012; 156 (12): 880-91.
Murillo R. Cervical cancer screening programs in Latin America and the Caribbean / R. Murillo // Vaccine. - 2008 (26). - P.37-48.
Paavonen J. Efficacy of human papillomavirus (HPV)-16/18 AS04 - adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA) : final analysis of a double-blind, randomised study in young women / J. Paavonen, P. Naud, J. Salmeron et al. // Lancet 2009; 374: 301–14.
Papanicolaou G.N. The diagnostic value of vaginal smears in carcinoma of the uterus / G.N. Papanicolaou, H. Traut // American Journal of Obstetrics and Gynecology. – 1941. – Vol. 42. – P. 193 – 205.
Papanicolaou G.N. A new procedure for staining vaginal smears / G.N. Papanicolaou // Science 1942. - Vol.95. - № 2469. - P.438-439.
Park J.Y. The association of pre – conization high – risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization / J.Y. Park, K.H. Lee, S.M. Dong et al. // Gynecol Oncol.- 2008.- 108(3): 549 – 54.
Parkin D.M. The burden of HPV-related cancers / D.M. Parkin, F. Bray // Vaccine.-2006. Vol.24 (Suppl.3) P.11-25.
Peto J. The cervical cancer epidemic that screening has prevented in the UK / J. Peto., C. Gilhem., O. Fletcher., F.E. Matthens // Lancet.- 2004.- Vol.364.- P.249 – 256.
Peto J. Time since first sexual intercourse and the risk of cervical cancer / J. Peto, M. Plummer, S. Franceschi // Int J Cancer. – 2012. – Vol. 130, №11. – P. 2638–2644.
Pileggi C. Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta – analysis of randomized controlled trials / C. Pileggi, D. Flotta, A. Bianco, C.G. Nobile, M. Pavia // Int J Cancer.- 2013. - Dec 3. doi: 10.1002/ijc.28640.
Population Estimates Program. Washington, D.C.: US Census Bureau; 2000. Available at: http://www.census.gov/population/ estimates/nation/intfile2-1.txt.
Realacci M. Detection of oncogenic HPV and identification of 72Arg polymorphic p53 by in situ PCR for clinical routine purposes / M. Realacci, G.A.Perrone, P.Sale et al. // Antican. Research. - 2006; Vol.26; 4: 3095-3103.
Rijkaart D.C. Human papillomavirus testing for the detection of high – grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomized controlled trail / D.C. Rijkaart, J.Berkhof, L. Rozendaal et al. // Lancet Oncol.-2012.- 13:78-88.
Ritchie J.M. The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus / J.M. Ritchie, E.M. Smith, K.F. Summersgill et al. // Int. J.Cancer 2003.- V.104.- №3. - P.336-344.
Rodriguez A.C. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infection / A.C. Rodriguez, M. Schiffman, R. Herrero, S. Wacholder, A. Hildesheim, P.E. Castie et al. // Journal of the National Cancer Institute 2008; 100 (7); 513-7.
Ronco G. Health technology assessment report: HPV DNA based primary screening for cervical cancer / G. Ronco, A. Biggeri, M. Confortini et al. // Epidemiol Prev.-2012.-May-Aug.-36 (3-4 Suppl): e1-72.
Ronco G. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four Europeen randomized controlled trials / G. Ronco, J. Dillner, K.M. Elfsröm et al. // The Lancet.-2013; doi:10.1016/S0140-6736(13)62218-7.
Saslou D. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer / D. Saslou, D. Solomon et al. // CA Cancer J Clin 2012; 62: 147-172.
Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing / M. Schiffman // Cancer 2007; 111 (3): 145-53.
Singh P. Neoadjuvant chemotherapy followed by radical vaginal trachelectomy and adjuvant chemotherapy for clear cell cancer of the cervix a feasible approach and review / P. Singh, J. Nicklin, T. Hassall // Int. J. Gynecol. Cancer.- 2011.- Vol.21.- P.137 – 140.
Singer A. Lower Genital Tract Precancer / A. Singer, J.M. Monaghan // Colposcopy Elseveor. - 2011.
Smith E.M. Human papillomavirus and types in newborns and parents / E.M. Smith E.M., J.M. Retchie, J. Yankowitz // Sexually transmitted diseases.- 2004. - Vol. 31 №1. P.57-62.
Smith J. Human papillomavirus type distribution in invasive cancer and high-grade cervical lesions: A meta-analysis update / J. Smith, L. Lindsay, B. Hoots et al. / Int J Cancer. - 2007. - №121. - P.621-632.
Snijders J. The value of viral load in HPV detection in screening / J. Snijders, C. Meijer // HPV Today. - 2006.-8.-P.8-9.
Solomon D. The Bethesda System for reporting cervical cytology. Definition, criteria, and explanatory notes / D. Solomon, R. Nayar // Springer.-2004.-XXIII. - Р.-191.
Stanley M.A. HPV: from infection / M.A. Stanley, M.R. Pett, N. Coleman // Biochem. Soc. Trans. – 2007. – Vol. 35, N 6. – P. 1456-1460.
Veldhuijzen N.J. Факторы, влияющие на передачу вируса папилломы слизистых оболочек человека / Nienke J Veldhuijzen, Peter JF Snijders, Peter Reiss, Chris JLM Meijer, Janneke HHM van de WijgertТом 2, номер 1, Январь-Февраль 2011 г. / // Том 2, номер 1, Январь-Февраль 2011 г. /@@The Lancet Infectious Diseases.- 2011 (2).- №1.
Wang Y.B. Prevalence of human papillomavirus in the pubic hair follicles of healthy men and male patients with genital warts / Y.B. Wang, T. Han, C.X. Zhao // Zhonghua Nan Ke Xue 2010; 16: 9: 783-785.
Winer R.L. Development and duration of human papillomavirus lesions after initial infection Text / R.L. Winer R.L. et al. // J. Infect. Dis. -2005. - Vol.191.- P.731-738.
Научная библиотека диссертаций и авторефератов disserCat http://www.dissercat.com/content/sovershenstvovanie-profilaktiki-boleznei-zhenskikh-polovykh-organov-i-papillomovirusnoi-infe#ixzz3FlIOPZrf
Workowski K.A., Berman S. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines. 2010. MMWR Recomm Rep 2010 Dec 17; 59 (RR-12): 1-110.
Wright T.C. Consensus Guidelines for the Management of Women with Cervical Intraepithelial Neoplasia / T.C. Wright, J.T. Cox, L.S. Massad // Genit.Tract Dis.-2003 Jul. - 7 (3): 154-167.
Wright T.C. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening / T.C. Wright, M. Schiffman, D. Solomon // Obstet Gynecol.- 2004 Feb.- 103 (2): 304-9.
Wittet S. All girls deserve protection from cervical cancer / S. Wittet // Geneva: GAVI Alliance. - 2009.
Woida Ch. Prevalence of cervical and intrauterine human papillomavirus infection in the third trimester in asymptomatic women / Ch. Woida, A.Huber, G. Hudelist // J. Soc. Gynec. Investing 2005. - Vol. 12. - P. 444-454.
World Health Organization (WHO). Comprehensive Cervical Cancer Control. A guide to essential practice. - Geneva; WHO 2006. Accessed 23 July 2009.
World Health Organization (WHO). Comprehensive cervical cancer control: a guide to essential practice. - Geneva, - 2010.
World Health Organization (WHO). Sexually transmitted infections. http://www.who.int/mediacentre/factsheets/fs110/en/ Информационный бюллетень N°110. Август 2011 г.
World Health Organization (WHO). HPV and disease prevention. ICO/WHO Monograph // Vaccine. - 2012. - 20 Nov. - Vol.30. - Suppl.5. - P. F55. - URL: www.sciencedirect.com.
Zhou X.B. Human Papillomavirus in Squamous Cell Carcinoma of Esophagus in a High-Risk Population / X.B. Zhuo, M. Guo, L.P. Quan et al. // World. J. Gastroenterol. - 2003. - V.9. - № 6. - P. 1170-1173.
Zur Hausen H. Condylomata acuminate and human genital cancer / H. Zur Hausen // Cancer Res 1976; 36:794.
Zur Hausen H. Papillomaviruses in the causation of human cancer – a brief historical account / H. Zur Hausen // Virology. – 2009; 384, 2:260-265.
|
